Patents by Inventor Rabinder Kumar Prinjha

Rabinder Kumar Prinjha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COVALENT CONJUGATES
    Publication number: 20190142949
    Abstract: The present invention relates to covalent conjugates of BET inhibitors and alpha amino acid esters, processes for their preparation, compositions containing them, and to their use in the treatment of various disorders in particular inflammatory and autoimmune diseases, such as rheumatoid arthritis; and cancers.
    Type: Application
    Filed: January 10, 2019
    Publication date: May 16, 2019
    Inventors: John Alexander BROWN, Katherine Louise Jones, Rabinder Kumar Prinjha, Jason Witherington
  • COVALENT CONJUGATES OF BET INHIBITORS AND ALPHA AMINO ACID ESTERS
    Publication number: 20180117165
    Abstract: The present invention relates to covalent conjugates of BET inhibitors and alpha amino acid esters, processes for their preparation, compositions containing them, and to their use in the treatment of various disorders in particular inflammatory and autoimmune diseases, such as rheumatoid arthritis; and cancers.
    Type: Application
    Filed: March 17, 2016
    Publication date: May 3, 2018
    Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: John Alexander BROWN, Katherine Louise JONES, Rabinder Kumar PRINJHA, Jason WITHERINGTON
  • Method of treatment
    Patent number: 9446041
    Abstract: The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 30, 2015
    Date of Patent: September 20, 2016
    Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
    Inventors: Anna K. Bassil, Soren Beinke, Rabinder Kumar Prinjha
  • METHOD OF TREATMENT
    Publication number: 20160074394
    Abstract: The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 30, 2015
    Publication date: March 17, 2016
    Inventors: Anna K. BASSIL, Soren BEINKE, Rabinder Kumar PRINJHA
  • Method of treatment
    Patent number: 9242962
    Abstract: The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: January 26, 2016
    Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
    Inventors: Anna K. Bassil, Soren Beinke, Rabinder Kumar Prinjha
  • METHOD OF TREATMENT
    Publication number: 20140256739
    Abstract: The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 2, 2012
    Publication date: September 11, 2014
    Inventors: Anna K. Bassil, Soren Beinke, Rabinder Kumar Prinjha
  • Immunoglobulins
    Patent number: 8362208
    Abstract: The present invention relates to antibodies to NOGO, pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorder.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: January 29, 2013
    Assignee: Glaxo Group Limited
    Inventors: Stephanie Jane Clegg, Jonathan Henry Ellis, Volker Germaschewski, Paul Andrew Hamblin, George Kopsidas, Ruth McAdam, Rabinder Kumar Prinjha
  • TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS BY NOGO-A-ANTAGONIST
    Publication number: 20110268729
    Abstract: The invention relates to methods for the treatment or prophylaxis of amyotrophic lateral sclerosis, comprising administering to a patient in need thereof a therapeutically effective amount of a Nogo-A antagonist.
    Type: Application
    Filed: July 10, 2009
    Publication date: November 3, 2011
    Inventors: Bams Abila, Sean Matthew Cleveland, Paul Andrew Hamblin, Rabinder Kumar Prinjha
  • NOGO-a neutralising immunoglobulin for treatment of neurological diseases
    Patent number: 7988964
    Abstract: The present invention provides immunoglobulins, particularly antibodies that bind to NOGO and neutralise the activity thereof, polynucleotides encoding such antibodies, pharmaceutical formulations containing said antibodies and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases.
    Type: Grant
    Filed: December 20, 2004
    Date of Patent: August 2, 2011
    Assignee: Glaxo Group Limited
    Inventors: Jonathan Henry Ellis, Alexandre Eon-Duval, Robert Ian Grundy, Farhana Hussain, Ruth McAdam, Christopher Plumpton, Rabinder Kumar Prinjha, Paul Alexander Wilson
  • IMMUNOGLOBULINS
    Publication number: 20100221260
    Abstract: The present invention relates to antibodies to NOGO, pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorder.
    Type: Application
    Filed: December 14, 2006
    Publication date: September 2, 2010
    Inventors: Stephanie Jane Clegg, Jonathan Henry Ellis, Volker Germaschewski, Paul Andrew Hamblin, George Kopsidas, Ruth McAdam, Rabinder Kumar Prinjha
  • MAGI POLYNUCLEOTIDES, POLYPEPTIDES, AND ANTIBODIES
    Publication number: 20090192294
    Abstract: MAGI polypeptides, polynucleotides, antibodies, and methods for producing the same by recombinant techniques are disclosed. Also disclosed are methods for utilizing MAGI polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: April 4, 2008
    Publication date: July 30, 2009
    Inventors: DAVID MICHALOVICH, RABINDER KUMAR PRINJHA
  • Novel compounds
    Publication number: 20020010324
    Abstract: MAGI polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing MAGI polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: February 21, 2001
    Publication date: January 24, 2002
    Inventors: David Michalovich, Rabinder Kumar Prinjha